Literature DB >> 29129786

Mechanisms by which a Very-Low-Calorie Diet Reverses Hyperglycemia in a Rat Model of Type 2 Diabetes.

Rachel J Perry1, Liang Peng2, Gary W Cline1, Yongliang Wang1, Aviva Rabin-Court1, Joongyu D Song1, Dongyan Zhang3, Xian-Man Zhang1, Yuichi Nozaki1, Sylvie Dufour3, Kitt Falk Petersen1, Gerald I Shulman4.   

Abstract

Caloric restriction rapidly reverses type 2 diabetes (T2D), but the mechanism(s) of this reversal are poorly understood. Here we show that 3 days of a very-low-calorie diet (VLCD, one-quarter their typical intake) lowered plasma glucose and insulin concentrations in a rat model of T2D without altering body weight. The lower plasma glucose was associated with a 30% reduction in hepatic glucose production resulting from suppression of both gluconeogenesis from pyruvate carboxylase (VPC), explained by a reduction in hepatic acetyl-CoA content, and net hepatic glycogenolysis. In addition, VLCD resulted in reductions in hepatic triglyceride and diacylglycerol content and PKCɛ translocation, associated with improved hepatic insulin sensitivity. Taken together, these data show that there are pleotropic mechanisms by which VLCD reverses hyperglycemia in a rat model of T2D, including reduced DAG-PKCɛ-induced hepatic insulin resistance, reduced hepatic glycogenolysis, and reduced hepatic acetyl-CoA content, PC flux, and gluconeogenesis.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  T2D; acetyl-CoA; caloric restriction; gluconeogenesis; glycogenolysis; type 2 diabetes; very low calorie diet; very-low-calorie diet

Mesh:

Substances:

Year:  2017        PMID: 29129786      PMCID: PMC5762419          DOI: 10.1016/j.cmet.2017.10.004

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  37 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

2.  PYRUVATE CARBOXYLASE. I. NATURE OF THE REACTION.

Authors:  M F UTTER; D B KEECH
Journal:  J Biol Chem       Date:  1963-08       Impact factor: 5.157

3.  PYRUVATE CARBOXYLASE. IV. PARTIAL REACTIONS AND THE LOCUS OF ACTIVATION BY ACETYL COENZYME A.

Authors:  M C SCRUTTON; D B KEECH; M F UTTER
Journal:  J Biol Chem       Date:  1965-02       Impact factor: 5.157

4.  Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes.

Authors:  Rachel J Perry; João-Paulo G Camporez; Romy Kursawe; Paul M Titchenell; Dongyan Zhang; Curtis J Perry; Michael J Jurczak; Abulizi Abudukadier; Myoung Sook Han; Xian-Man Zhang; Hai-Bin Ruan; Xiaoyong Yang; Sonia Caprio; Susan M Kaech; Hei Sook Sul; Morris J Birnbaum; Roger J Davis; Gary W Cline; Kitt Falk Petersen; Gerald I Shulman
Journal:  Cell       Date:  2015-02-05       Impact factor: 41.582

5.  A possible role for acetyl CoA in the control of gluconeogenesis.

Authors:  M F Utter; D B Keech; M C Scrutton
Journal:  Adv Enzyme Regul       Date:  1964

6.  Comparison of glucostatic parameters after hypocaloric diet or bariatric surgery and equivalent weight loss.

Authors:  Leona Plum; Leaque Ahmed; Gerardo Febres; Marc Bessler; William Inabnet; Elizabeth Kunreuther; Donald J McMahon; Judith Korner
Journal:  Obesity (Silver Spring)       Date:  2011-05-19       Impact factor: 5.002

7.  Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells.

Authors:  N Marx; U Schönbeck; M A Lazar; P Libby; J Plutzky
Journal:  Circ Res       Date:  1998-11-30       Impact factor: 17.367

8.  Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes.

Authors:  Blandine Laferrère; Julio Teixeira; James McGinty; Hao Tran; Joseph R Egger; Antonia Colarusso; Betty Kovack; Baani Bawa; Ninan Koshy; Hongchan Lee; Kimberly Yapp; Blanca Olivan
Journal:  J Clin Endocrinol Metab       Date:  2008-04-22       Impact factor: 5.958

Review 9.  The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes.

Authors:  Rachel J Perry; Varman T Samuel; Kitt F Petersen; Gerald I Shulman
Journal:  Nature       Date:  2014-06-05       Impact factor: 49.962

10.  A Non-invasive Method to Assess Hepatic Acetyl-CoA In Vivo.

Authors:  Rachel J Perry; Liang Peng; Gary W Cline; Kitt Falk Petersen; Gerald I Shulman
Journal:  Cell Metab       Date:  2017-01-19       Impact factor: 27.287

View more
  25 in total

1.  [Effect of glucagon-like peptide 1 receptor agonists on body fat redistribution and muscle mass in overweight and obese type 2 diabetic patients].

Authors:  Yudan Zhang; Shiqun Liu; Cunxia Fan; Yanmei Zeng; Jimin Li; Cuihua Xie; Yaoming Xue; Meiping Guan
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-04-30

2.  Emerging Pharmacological Targets for the Treatment of Nonalcoholic Fatty Liver Disease, Insulin Resistance, and Type 2 Diabetes.

Authors:  Leigh Goedeke; Rachel J Perry; Gerald I Shulman
Journal:  Annu Rev Pharmacol Toxicol       Date:  2019-01-06       Impact factor: 13.820

Review 3.  Current treatments for obesity.

Authors:  Aruchuna Ruban; Kostadin Stoenchev; Hutan Ashrafian; Julian Teare
Journal:  Clin Med (Lond)       Date:  2019-05       Impact factor: 2.659

Review 4.  Mechanisms of Insulin Action and Insulin Resistance.

Authors:  Max C Petersen; Gerald I Shulman
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

5.  A Membrane-Bound Diacylglycerol Species Induces PKCϵ-Mediated Hepatic Insulin Resistance.

Authors:  Kun Lyu; Ye Zhang; Dongyan Zhang; Mario Kahn; Kasper W Ter Horst; Marcos R S Rodrigues; Rafael C Gaspar; Sandro M Hirabara; Panu K Luukkonen; Seohyuk Lee; Sanjay Bhanot; Jesse Rinehart; Niels Blume; Morten Grønbech Rasch; Mireille J Serlie; Jonathan S Bogan; Gary W Cline; Varman T Samuel; Gerald I Shulman
Journal:  Cell Metab       Date:  2020-09-02       Impact factor: 27.287

6.  Controlled-release mitochondrial protonophore (CRMP) reverses dyslipidemia and hepatic steatosis in dysmetabolic nonhuman primates.

Authors:  Leigh Goedeke; Liang Peng; Valle Montalvo-Romeral; Gina M Butrico; Sylvie Dufour; Xian-Man Zhang; Rachel J Perry; Gary W Cline; Paul Kievit; Keefe Chng; Kitt Falk Petersen; Gerald I Shulman
Journal:  Sci Transl Med       Date:  2019-10-02       Impact factor: 17.956

7.  Novel Strategies to Treat Hepatic Steatosis and Steatohepatitis.

Authors:  Rachel J Perry
Journal:  Obesity (Silver Spring)       Date:  2019-07-25       Impact factor: 5.002

Review 8.  The integrative biology of type 2 diabetes.

Authors:  Michael Roden; Gerald I Shulman
Journal:  Nature       Date:  2019-12-04       Impact factor: 49.962

Review 9.  The Impact of Fasting on Major Metabolic Pathways of Macronutrients and Pharmacokinetics Steps of Drugs.

Authors:  Reza Karimi; Anita Cleven; Fawzy Elbarbry; Huy Hoang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2021-01       Impact factor: 2.441

10.  A MicroRNA Linking Human Positive Selection and Metabolic Disorders.

Authors:  Lifeng Wang; Nasa Sinnott-Armstrong; Alexandre Wagschal; Abigail R Wark; Joao-Paulo Camporez; Rachel J Perry; Fei Ji; Yoojin Sohn; Justin Oh; Su Wu; Jessica Chery; Bahareh Nemati Moud; Alham Saadat; Simon N Dankel; Gunnar Mellgren; Divya Sri Priyanka Tallapragada; Sophie Madlen Strobel; Mi-Jeong Lee; Ryan Tewhey; Pardis C Sabeti; Anne Schaefer; Andreas Petri; Sakari Kauppinen; Raymond T Chung; Alexander Soukas; Joseph Avruch; Susan K Fried; Hans Hauner; Ruslan I Sadreyev; Gerald I Shulman; Melina Claussnitzer; Anders M Näär
Journal:  Cell       Date:  2020-10-14       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.